121 related articles for article (PubMed ID: 35312295)
1. Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis.
Balachandran YL; Wang W; Yang H; Tong H; Wang L; Liu F; Chen H; Zhong K; Liu Y; Jiang X
ACS Nano; 2022 Apr; 16(4):5647-5659. PubMed ID: 35312295
[TBL] [Abstract][Full Text] [Related]
2. New Class of Efficient T
Yue H; Park JA; Ho SL; Ahmad MY; Cha H; Liu S; Tegafaw T; Marasini S; Ghazanfari A; Kim S; Chae KS; Chang Y; Lee GH
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33076332
[TBL] [Abstract][Full Text] [Related]
3. Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer.
Hu H; Zhang Y; Shukla S; Gu Y; Yu X; Steinmetz NF
ACS Nano; 2017 Sep; 11(9):9249-9258. PubMed ID: 28858475
[TBL] [Abstract][Full Text] [Related]
4. Theranostic Iron Oxide/Gold Ion Nanoprobes for MR Imaging and Noninvasive RF Hyperthermia.
Fazal S; Paul-Prasanth B; Nair SV; Menon D
ACS Appl Mater Interfaces; 2017 Aug; 9(34):28260-28272. PubMed ID: 28789518
[TBL] [Abstract][Full Text] [Related]
5. Engineering manganese ferrite shell on iron oxide nanoparticles for enhanced T
Li M; Bao J; Zeng J; Huo L; Shan X; Cheng X; Qiu D; Miao W; Zhu X; Huang G; Ni K; Zhao Z
J Colloid Interface Sci; 2022 Nov; 626():364-373. PubMed ID: 35797871
[TBL] [Abstract][Full Text] [Related]
6. Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles.
Xu K; Liu H; Zhang J; Tong H; Zhao Z; Zhang W
Int J Nanomedicine; 2019; 14():7879-7889. PubMed ID: 31576129
[TBL] [Abstract][Full Text] [Related]
7. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Testing of Modular Dual-Modality Nanoparticles for Magnetic Resonance and Multispectral Photoacoustic Imaging.
Bogdanov AA; Dixon AJ; Gupta S; Zhang L; Zheng S; Shazeeb MS; Zhang S; Klibanov AL
Bioconjug Chem; 2016 Feb; 27(2):383-90. PubMed ID: 26603129
[TBL] [Abstract][Full Text] [Related]
9. NaDyF4 Nanoparticles as T2 Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging.
Das GK; Johnson NJ; Cramen J; Blasiak B; Latta P; Tomanek B; van Veggel FC
J Phys Chem Lett; 2012 Feb; 3(4):524-9. PubMed ID: 26286058
[TBL] [Abstract][Full Text] [Related]
10. One-step, room-temperature synthesis of glutathione-capped iron-oxide nanoparticles and their application in in vivo T1-weighted magnetic resonance imaging.
Liu CL; Peng YK; Chou SW; Tseng WH; Tseng YJ; Chen HC; Hsiao JK; Chou PT
Small; 2014 Oct; 10(19):3962-9. PubMed ID: 25044378
[TBL] [Abstract][Full Text] [Related]
11. Iron-oxide-based twin nanoplates with strong T
Wei R; Zhou T; Sun C; Lin H; Yang L; Ren BW; Chen Z; Gao J
Nanoscale; 2018 Oct; 10(38):18398-18406. PubMed ID: 30256373
[TBL] [Abstract][Full Text] [Related]
12. Octapod iron oxide nanoparticles as high-performance T₂ contrast agents for magnetic resonance imaging.
Zhao Z; Zhou Z; Bao J; Wang Z; Hu J; Chi X; Ni K; Wang R; Chen X; Chen Z; Gao J
Nat Commun; 2013; 4():2266. PubMed ID: 23903002
[TBL] [Abstract][Full Text] [Related]
13. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
[TBL] [Abstract][Full Text] [Related]
14. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging.
Yuk SH; Oh KS; Cho SH; Lee BS; Kim SY; Kwak BK; Kim K; Kwon IC
Biomacromolecules; 2011 Jun; 12(6):2335-43. PubMed ID: 21506550
[TBL] [Abstract][Full Text] [Related]
15. Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via
Zhang J; Ning Y; Zhu H; Rotile NJ; Wei H; Diyabalanage H; Hansen EC; Zhou IY; Barrett SC; Sojoodi M; Tanabe KK; Humblet V; Jasanoff A; Caravan P; Bawendi MG
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2220036120. PubMed ID: 37094132
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Nimi N; Arumugam S; Shenoy SJ; Jayasree RS
Carbohydr Polym; 2014 Jan; 101():760-8. PubMed ID: 24299836
[TBL] [Abstract][Full Text] [Related]
17. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T₂ MRI contrast agents.
Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
Biomaterials; 2012 Apr; 33(11):3254-61. PubMed ID: 22277624
[TBL] [Abstract][Full Text] [Related]
18. Outstanding MRI contrast with dysprosium phosphate nanoparticles of tuneable size.
Gómez-González E; Caro C; García-Martín ML; Becerro AI; Ocaña M
Nanoscale; 2022 Aug; 14(31):11461-11470. PubMed ID: 35904370
[TBL] [Abstract][Full Text] [Related]
19. Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles.
Xu C; Miranda-Nieves D; Ankrum JA; Matthiesen ME; Phillips JA; Roes I; Wojtkiewicz GR; Juneja V; Kultima JR; Zhao W; Vemula PK; Lin CP; Nahrendorf M; Karp JM
Nano Lett; 2012 Aug; 12(8):4131-9. PubMed ID: 22769232
[TBL] [Abstract][Full Text] [Related]
20. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
